Cancer cells not only evade immune recognition by downregulating or deleting the surface molecules required for antigen recognition but can also often hijack the immunosuppression system, including immune checkpoints like the PD-1/PD-L1 axis, to suppress T-cell activity at the tumor site [67]. Here, CD274 is linked to neoplasm.